1. Home
  2. HAFC vs IART Comparison

HAFC vs IART Comparison

Compare HAFC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanmi Financial Corporation

HAFC

Hanmi Financial Corporation

HOLD

Current Price

$30.06

Market Cap

821.2M

Sector

Finance

ML Signal

HOLD

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

HOLD

Current Price

$15.32

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAFC
IART
Founded
1982
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
821.2M
1.1B
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
HAFC
IART
Price
$30.06
$15.32
Analyst Decision
Hold
Hold
Analyst Count
3
7
Target Price
$32.17
$14.33
AVG Volume (30 Days)
219.8K
1.1M
Earning Date
04-21-2026
05-05-2026
Dividend Yield
3.75%
N/A
EPS Growth
22.44
N/A
EPS
0.75
N/A
Revenue
$270,165,000.00
N/A
Revenue This Year
$18.65
$4.39
Revenue Next Year
$7.28
$3.40
P/E Ratio
$39.32
N/A
Revenue Growth
15.28
N/A
52 Week Low
$21.84
$8.70
52 Week High
$31.33
$16.42

Technical Indicators

Market Signals
Indicator
HAFC
IART
Relative Strength Index (RSI) 58.32 72.78
Support Level $29.20 $12.64
Resistance Level $30.47 $16.35
Average True Range (ATR) 0.59 0.90
MACD -0.14 0.15
Stochastic Oscillator 64.78 99.59

Price Performance

Historical Comparison
HAFC
IART

About HAFC Hanmi Financial Corporation

Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

Share on Social Networks: